Michel Vulfovich

1.9k citations
9 papers · 145 indexed · 1 hit paper · h-index 6
Topics
Pancreatic and Hepatic Oncology Research (2 papers)HER2/EGFR in Cancer Research (2 papers)Cancer Genomics and Diagnostics (2 papers)
Partner nations
United States

In The Last Decade

Michel Vulfovich

9 papers receiving 140 citations

Hit Papers

Folate Receptor Alpha—A Novel Approach to Cancer Therapy20242026202520241020304050

Peers

Michel Vulfovich
Comparison fields: 5 of 45
  • Oncology 59
  • Molecular Biology 54
  • Cancer Research 23
  • Radiology, Nuclear Medicine and Imaging 19
  • Biomedical Engineering 18
Replace Vanessa Klapp with:
Vanessa Klapp United States
Ziqi Jia China
Marina Natoli Switzerland
Ryan M. Winters United States
Fumito Tamura Japan
Isaure Vanmeerbeek Belgium
Caitlin M. Tilsed Australia
Yueyao Yang China
Kazuya Arai United States
Michel Vulfovich relative to Vanessa Klapp United States Vanessa Klapp's profile →
Citations per field
00.5×1.5×
Vanessa Klapp · 1×
Citations per year

Countries citing papers authored by Michel Vulfovich

Since Specialization
Citations

This map shows the geographic impact of Michel Vulfovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vulfovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vulfovich more than expected).

Fields of papers citing papers by Michel Vulfovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Vulfovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vulfovich. The network helps show where Michel Vulfovich may publish in the future.

Co-authorship network of co-authors of Michel Vulfovich

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vulfovich. A scholar is included among the top collaborators of Michel Vulfovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vulfovich. Michel Vulfovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 6
2 19
3
Folate Receptor Alpha—A Novel Approach to Cancer Therapybreakdown →
52
4 1
5 1
6 3
7 46
8
Technology evaluation: mapatumumab, Human Genome Sciences/GlaxoSmithKline/Takeda.
10
9 7

About Michel Vulfovich

Michel Vulfovich is a scholar working on Cancer Research, Oncology and Neurology, having authored 9 papers that have together received 145 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (59 citations), Biotechnology (16 citations) and Cancer Research (23 citations). Michel Vulfovich has collaborated with scholars based in United States. Frequent co-authors include Caio Rocha-Lima, Teresita Pérez González, Nabil F. Saba, Atif Hussein, Arjun Khunger, Pasquale Benedetto, Caio Max S. Rocha Lima, Caio Rocha‐Lima, Muaiad Kittaneh and Kelly King. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026